Precision, speed, and reliability — powering better decisions in healthcare and public safety for you.

       YEARS IN

RAPID TEST

10+

Learn more 

about CNDH

GET IN TOUCH

Keep Professional

Established in November 2020, Nano Diagnosis for Health Biotech (Guangzhou) Co., Ltd. (abbreviated as CNDH), has been jointly incubated by The GBA National Institute for Nanotechnology Innovation and National Engineering Research Center for Nanomedicine. CNDH is a high-tech enterprise focusing on the research, development, production and sales of in vitro diagnostic equipment and reagents for drugs of abuse, human diseases, and animal diseases.

White multi-story building labeled "D" with large windows, trees in the foreground, and a blue sky above.

100+

CE-certified products

100+

patent applications

70+

authorized patents 

Guangdong Provicial People's Government 

Ministry of Science and Technology

The GBA National Institute for 

Nanotechnology Innovation

 Chinese Academy of Sciences 

 Huazhong University of Science 

and Technology

National Center for Nanoscience 

and Technology

 Guangzhou high-tech Industrial 

Development Zone

Nano Diagnosis for Health Biotech 

(Guangzhou) Co., Ltd

National Engineering Research 

Center for Nanomedicine

CNDH logo with green and blue text, "Nano Diagnosis for Health."nano logo.pngcannano logo.png

丨

丨

丨

丨

丨

丨

丨

Establishment Background

Core Team Leader

     From the perspective of the human life process, the nanoscale represents the critical threshold between non-living and living matter. Therefore, regulating life processes, disease onset and progression, as well as diagnosing, controlling, and treating diseases at the nanoscale is ultimately the most efficient approach.

Academician, Chinese Academy of Sciences (CAS)

Director, National Engineering Research Center for Nanoscience

President, The GBA National Institute for Nanotechnology Innovation (CanNano)

Academician, Chinese Academy of Sciences (CAS)

Director, National Center for Nanoscience

President, The GBA National Institute for Nanotechnology Innovation (CanNano)

Director of Technical Committee, National Engineering Research Center for Nanomedicine

Director of Technical Committee, National Engineering Research Center for Nanomedicine

Prof. Zhao Yuliang 

      The "Five Principles" for targeted delivery of antitumor nanomedicines state that an effective nanomedicine must be able to: “long circulation”, “tumor accumulation”  “deep” , “cellular internalization” , and “drug release” .

Director, National Engineering Research Center for Nanomedicine

Chief Scientist, National Major Scientific Research Program (973)

Leader, National innovation team in key areas

Member of Expert Group, National Key R&D Program of Nanotechnology

Prof. Yang Xiangliang 

core team leader 2.jpgcore team leader 1.jpg

Certifications

NEW PRODUCTS, GREAT DEALS.1

Welcome to our house, it makes your life better.
ISO qualified & 100+ CE-certified products

Reagent Workshop

CNDH has equipped with internationally advanced R&D laboratory and production facilities.

Automated manufacturing machine in a clean, white industrial room.Automated High-Precision Reagent Dispenser

Stringent ISO 13485 controls. Automated lines ensure ultra-low CVs for batch-to-batch fidelity

Contact Us

Have any question or feedback, feel free to reach out to us. We are always available to help.

Reach Out to Us

Please kindly provide us with your contact details such as your name, phone number, and email address so that we can get in touch with you at the earliest convenience.

+86 20 28399556

7F&8F, D Bldg. No. 136 Kaiyuan Avenue, Huangpu District, Guangzhou, China 510535

WhatsApp